Abstract 1117P
Background
Skin melanoma, particularly acral melanoma, is known for its poor prognosis, often exacerbated by infections and chronic ulcers. Recent research has highlighted the significant role of intratumoral microbiota in various cancers, but its impact remains less understood in Chinese patients with skin melanoma. This study aims to investigate the intratumoral microbiota in melanoma among this group and explore its potential influence on disease progression.
Methods
One hundred melanoma tissue samples from stage III/IV skin or acral melanoma patients at Sun Yat-sen University Cancer Center, collected between 2015 and 2021, were retrospectively collected and underwent LPS immunohistochemistry (IHC). Kaplan-Meier analysis was used to assess the relation of LPS expression and patients overall survival. Microbial diversity was analyzed through 16S rRNA sequencing. Spatial transcriptomics was applied to map LPS-positive and LPS-negative regions, enabling the exploration of transcriptional differences and cell distributions.
Results
Patients with high LPS levels exhibited a median overall survival (mOS) of 13.7 months (95% CI, 10.6–16.9), which was shorter compared to those with low LPS levels, who had not yet reached median survival. Analysis of tumor microbiota revealed significant diversity, with high proportions of Bifidobacterium, Vibrio, Bacillus, Clostridium sensu stricto, and Pseudomonas, among which Pseudomonas was the dominant genus. Spatial transcriptomic analysis of LPS-positive melanoma tissues showed an increased proportion of M2 macrophages and a decreased proportion of effector T cells. Gene set enrichment analysis (GSEA) further indicated the activation of epithelial-mesenchymal transition (EMT) pathways.
Conclusions
High levels of microbiota within melanoma tissues are correlated with poor overall survival and may facilitate tumor immune evasion and metastasis.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1111P - Genomic and transcriptomic analysis of Japanese melanoma reveals candidate biomarkers for immune checkpoint inhibitor responders
Presenter: Toshihiro Kimura
Session: Poster session 04
1112P - Immunotherapy after progression to double immunotherapy: Pembrolizumab and Lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibition
Presenter: Dimitrios Ziogas
Session: Poster session 04
1113P - A machine learning model based on computed tomography radiomics to predict prognosis in subjects with stage IV melanoma
Presenter: Maria Teresa Maccallini
Session: Poster session 04
1114P - Deciphering unresectable in-transit metastasis in melanoma: Multi-modal and longitudinal insights
Presenter: Giuseppe Tarantino
Session: Poster session 04
1115P - Multiomics clustering of patients with cutaneous melanoma to reveal survival trends based on tumor immune evasion features
Presenter: Adeliya Leleytner
Session: Poster session 04
1116P - Application of the Scottish inflammatory prognostic score to the south-east Scotland cancer network real-world melanoma cohort
Presenter: Karim El-Shakankery
Session: Poster session 04
1118P - Immunological alterations during neoadjuvant BRAF/MEK inhibition in patients with prior unresectable regionally advanced melanoma: Translational analysis from the REDUCTOR trial
Presenter: Femke Burgers
Session: Poster session 04
1119P - Genomic and transcriptomic predictors of resistance to anti-PD1 monotherapy in patients with advanced melanoma
Presenter: Wenya Wang
Session: Poster session 04
1120P - Tumoral and peripheral immunophenotype of patients with stage II/III melanoma undergoing adjuvant immunotherapy following tumor resection
Presenter: Maria Ascierto
Session: Poster session 04
1121P - Artificial Intelligence to predict BRAF mutational status from whole slide images in melanoma
Presenter: Céline Bossard
Session: Poster session 04